Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03929211
Title CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field